137 related articles for article (PubMed ID: 16081472)
21. Alpha-2b recombinant interferon (Intron-A) as maintenance treatment in multiple myeloma.
Avvisati G; Petrucci MT; Pulsoni A; Tribalto M; Lauta VM; Gernone A; Boccadoro M; Marmont F; Pileri A; Dammacco F
Eur J Haematol Suppl; 1990; 52():9-11. PubMed ID: 2279547
[No Abstract] [Full Text] [Related]
22. The role of alpha-interferon in multiple myeloma.
Peest D
Pathol Biol (Paris); 1999 Feb; 47(2):172-7. PubMed ID: 10192884
[TBL] [Abstract][Full Text] [Related]
23. Thalidomide-dexamethasone versus interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study.
Offidani M; Corvatta L; Polloni C; Piersantelli MN; Gentili S; Galieni P; Visani G; Alesiani F; Catarini M; Brunori M; Samori A; Burattini M; Centurioni R; Ferranti M; Giuliodori L; Candela M; Mele A; Marconi M; Leoni P
Br J Haematol; 2009 Mar; 144(5):653-9. PubMed ID: 19036082
[TBL] [Abstract][Full Text] [Related]
24. Multiple myeloma.
Bataille R; Harousseau JL
N Engl J Med; 1997 Jun; 336(23):1657-64. PubMed ID: 9171069
[No Abstract] [Full Text] [Related]
25. Interferon-alpha treatment in multiple myeloma: meta-analysis of 30 randomised trials among 3948 patients.
Fritz E; Ludwig H
Ann Oncol; 2000 Nov; 11(11):1427-36. PubMed ID: 11142483
[TBL] [Abstract][Full Text] [Related]
26. A patient with multiple myeloma, amyloidosis and light-chain deposition disease in kidneys with a long survival.
Christou L; Hatzimichael EC; Sotsiou-Candila F; Siamopoulos K; Bourantas KL
Acta Haematol; 1999; 101(4):202-5. PubMed ID: 10436302
[TBL] [Abstract][Full Text] [Related]
27. Health-related quality of life and patients' perceptions in interferon-treated multiple myeloma patients. Nordic Myeloma Study Group.
Wisløff F; Gulbrandsen N
Acta Oncol; 2000; 39(7):809-13. PubMed ID: 11145438
[TBL] [Abstract][Full Text] [Related]
28. Role of alpha interferon in multiple myeloma.
Joshua DE; MacCallum S; Gibson J
Blood Rev; 1997 Dec; 11(4):191-200. PubMed ID: 9481449
[TBL] [Abstract][Full Text] [Related]
29. Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study.
Salmon SE; Crowley JJ; Grogan TM; Finley P; Pugh RP; Barlogie B
J Clin Oncol; 1994 Nov; 12(11):2405-14. PubMed ID: 7964957
[TBL] [Abstract][Full Text] [Related]
30. [Alpha-interferon in present-day treatment of myeloma].
Demina EA; Votiakova OM
Gematol Transfuziol; 1996; 41(2):32-6. PubMed ID: 8754159
[No Abstract] [Full Text] [Related]
31. [Quality of life and tolerance of maintenance therapy in patients with multiple myeloma].
Adam Z; Pour L; Svobodník A; Scudla V; Salajka F; Vytrasová M; Bacovský J; Schützová M; Koza V; Sumná E; Franková H; Lehanka F; Gumulec J; Stavarová Y; Cahová S; Vránová M; Dostálová V; Kessler P; Walterová L; Meluzínová I; Seifertová N; Sláma O; Büchler T; Krejcí M; Bencíková V; Nykodýmová V; Dusek L; Hájek R;
Vnitr Lek; 2002 Mar; 48(3):216-29. PubMed ID: 11968583
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation.
Biagi JJ; Mileshkin L; Grigg AP; Westerman DW; Prince HM
Bone Marrow Transplant; 2001 Dec; 28(12):1145-50. PubMed ID: 11803357
[TBL] [Abstract][Full Text] [Related]
33. Maintenance therapy for multiple myeloma with particular emphasis on thalidomide.
Dürk HA
Onkologie; 2006 Dec; 29(12):582-90. PubMed ID: 17202830
[TBL] [Abstract][Full Text] [Related]
34. [Role of interferon for the treatment of myeloma].
Tomita S; Okamoto S
Nihon Rinsho; 2007 Dec; 65(12):2285-90. PubMed ID: 18069274
[TBL] [Abstract][Full Text] [Related]
35. [Use of interferon alpha in multiple myeloma].
Harousseau JL; Klein B
Rev Med Interne; 1996; 17(6):488-95. PubMed ID: 8758538
[TBL] [Abstract][Full Text] [Related]
36. Should-alpha-interferon be included as standard treatment in multiple myeloma?
Ludwig H; Fritz E; Zulian GB; Browman GP
Eur J Cancer; 1998 Jan; 34(1):12-24. PubMed ID: 9624233
[No Abstract] [Full Text] [Related]
37. New agents for the treatment of multiple myeloma and non-Hodgkin lymphoma.
Oken MM
Cancer; 1992 Aug; 70(4 Suppl):946-8. PubMed ID: 1638466
[TBL] [Abstract][Full Text] [Related]
38. [Maintenance therapies of thalidomine and interferon-α in multiple myeloma].
Li J; Cai JH; Huang BH; Liu JR; Zheng D
Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(48):3417-20. PubMed ID: 22333255
[TBL] [Abstract][Full Text] [Related]
39. Photosensitive seizures associated with interferon alfa-2a.
Brouwers PJ; Bosker RJ; Schaafsma MR; Wilts G; Neef C
Ann Pharmacother; 1999 Jan; 33(1):113-4. PubMed ID: 9972396
[No Abstract] [Full Text] [Related]
40. A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results.
Cunningham D; Powles R; Malpas J; Raje N; Milan S; Viner C; Montes A; Hickish T; Nicolson M; Johnson P; Treleaven J; Raymond J; Gore M
Br J Haematol; 1998 Jul; 102(2):495-502. PubMed ID: 9695964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
